Japan's Astellas Pharma announces strategic collaboration with US-based Mass General Brigham

Japan-based Astellas Pharma Inc. has entered into a strategic collaboration with US-based Mass General Brigham ...

January 31, 2024 | Wednesday | News
Saudi Arabia approves first CRISPR/Cas9 gene-edited therapy for treatment of sickle cell disease

US-based Vertex Pharmaceuticals Incorporated has announced that the Saudi Food and Drug Authority (SFDA) has g...

January 12, 2024 | Friday | News
Novel CAR T-cell therapy regimen to augment oncology care for hard-to-treat cancers

Tony Li, Senior Director and Head of Medical Affairs, Intercontinental Region, Gilead and Kite Oncology Kite Pharma, a ...

January 11, 2024 | Thursday | Opinion
MarkHerz and Polyplus Collaborate to Advance Cell and Gene Therapy Process Standards and Lower Costs

The teams will work to improve process efficiency leveraging Polyplus products and expertise with MarkHerz man...

December 19, 2023 | Tuesday | News
Enhancing Cell and Gene Therapy scalability in Asia using 3D manufacturing platforms with microcarrier technology

Dr. Liu Wei Co-founder & CEO, CytoNiche, Shanghai, China China-based CytoNiche Biotechnology, a pioneer in 3D disso...

July 3, 2023 | Monday | Opinion